Safety Study In Patients Who Were Born Small And Short And Were Treated With Growth Hormone To Achieve Normal Height

Inclusion Criteria: * Patients with SGA treated with growth hormone in one of the following Genotropin studies (89-041, 89-070/071, 90-079, 90-080/98-8122-011) for at least 3 years and after having stopped GH treatment for 5-10 years * Untreated SGA (based on birth weight and/or length below -2 standard deviations \[SDs\] for gestational age) matched to treated SGA by body mass index (+ or = 10%) and gender: * Subjects born SGA with normal final height (within +/- 1.3 SD of their target height); or * Subjects born SGA with short stature (height SDs \> 1.3 below target at final height). Exclusion Criteria: * Known diabetes type 1 or 2, or 1st degree relative of a patient with diabetes type 2 * Familial dyslipidemia